Global Phase 3 innovaTV301 Trial Results
Trial investigator Brian Slomovitz, MD, Director of Gynecologic Oncology and Co-Chair of the Cancer Research Committee at Mount Sinai Medical Center, di...
270 articles
Trial investigator Brian Slomovitz, MD, Director of Gynecologic Oncology and Co-Chair of the Cancer Research Committee at Mount Sinai Medical Center, di...
Deepak Bhatt, MD, MPH, Director of Mount Sinai Heart and Principal Study Author discusses the final dataset from the Phase 2 ENTRIGUE trial of 89bio’s...
Lee, MD, Cherng Family Director's Chair, Center for Integrative Oncology at City of Hope, one of the largest cancer research and treatment organizations...
KimberLee Heidmann, Executive Vice President of Patient Experience and Customer Success at Scout Clinical, part of the Meeting Protocol Worldwide family...
Andrea Furlan, MD, PhD, Associate Professor in the Department of Medicine at the University of Toronto and a Staff Physician and Senior Scientist at the...
Christopher Flowers, M.D., Department of Lymphoma - Myeloma, Division of Cancer Medicine and chair of Lymphoma & Myeloma at The University of Texas MD A...
Steve Marcus, CEO of Cantex Pharmaceuticals, a clinical-stage pharmaceutical company focused on developing transformative therapies for cancer and other...
Greg Pierce, SVP and GM of Specialty, Health & Wellness at Synchrony, a financial services company, discusses the over-the-counter (OTC) hearing aids ru...
Elizabeth Garner, MD, Chief Scientific Officer for Ferring Pharmaceuticals discusses C. Learn more on Health Professional Radio.
Corey Cutler, MD, MPH, FRCPC, Medical Director, Stem Cell Transplant Program, Dana-Farber Cancer Institute and Vice President, American Society for Tran...